Completed
Heterosexual HIV Transmission Study (HATS)
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2016-10-06
N/A
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
PRIMARY: To identify sexual behaviors and biological factors associated with an increased risk of heterosexual HIV transmission. SECONDARY: To assess the effect of safer sex counseling on behavior of sexually active heterosexuals in which one member of the couple is infected with HIV. To create a repository of serum, peripheral blood mononuclear cells, semen, and cervico-vaginal washings from heterosexual couples who are concordant (both partners HIV infected) and discordant (one partner HIV infected) with respect to HIV infection. In the United States, the number of AIDS cases attributed to heterosexual transmission, although still a small percentage of the total number of reported cases, is the most rapidly growing category. The rate at which HIV is transmitted between heterosexual couples and the factors that may impede or enhance heterosexual transmission are important to understanding and slowing the worldwide HIV epidemic.
CONDITIONS
Official Title
Heterosexual HIV Transmission Study (HATS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
Inclusion Criteria
Risk Behavior:
PART B ONLY:
- HIV-infected partner (primary partner) must have a known risk factor for HIV infection, such as
- Bisexual male.
- IV drug user.
- Hemophiliac male.
- Recipient of HIV-contaminated transfusion.
Participants must meet the following criteria:
- Heterosexual couples in which at least one member is HIV-infected. Comparison group consists of heterosexual couples concordant that are both HIV infected.
- Able to speak English or Spanish.
PART A secondary partners:
- Risk factor for HIV infection other than heterosexual contact, such as
- Evidence of any past or present parenteral drug use by self report, physical examination, or urine test.
- History of homosexual activity (if male) within 5 years prior to study entry.
PART B secondary partners:
- Risk factor for HIV infection other than sexual contact with the primary partner, such as
- Evidence of any past or present parenteral drug use by self-report or by urine test.
- History of homosexual activity (if male) at any time since 1978.
- Sexual contact with another person with an HIV risk factor at any time since 1978, unless secondary partner is documented to be HIV uninfected subsequent to the last contact with such person.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Total: 1 location
1
UMDNJ - New Jersey Med School
Newark, New Jersey, United States, 071032757
Status Unknown
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here